Published in:
01-02-2004 | Poster presentation
Recombinant human activated protein C upregulates cyclooxygenase-2 and release of prostaglandins from cultured human endothelial cells via the endothelial protein C receptor
Authors:
M Brueckmann, K Fukudome, S Horn, S Lang, V Liebe, U Hoffmann, M Borggrefe, K Haase, G Huhle
Published in:
Critical Care
|
Special Issue 1/2004
Login to get access
Excerpt
Cyclooxygenase-2 (COX-2) is the inducible COX isoform that catalyzes the formation of prostaglandins in response to proinflammatory cytokines. Prostacyclin, the major prostanoid generated by endothelial cells, is a potent inhibitor of platelet aggregation and a powerful vasodilator. Although the role of Drotrecogin alfa (activated) (recombinant human activated protein C [rhAPC]) in modulating microvascular coagulation through the inhibition of thrombin generation has been well studied in experimental and clinical settings of severe sepsis, little is known about its effects on prostanoid release from endothelial cells. …